#Catheter-Related Bloodstream Infection Drugs Market trends | Explore Tumblr posts and blogs

businessindustry · 3 months ago

Text

Catheter-Related Bloodstream Infection Drugs Market Size | Overview and Future News by 2032

The Reports and Insights, a leading market research company, has recently releases report titled “Catheter-Related Bloodstream Infection Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Catheter-Related Bloodstream Infection Drugs Market Share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Catheter-Related Bloodstream Infection Drugs Market?

The global catheter-related bloodstream infection drugs market was valued at US$ 1.6 Billion in 2023 and is expected to register a CAGR of 5.7% over the forecast period and reach US$ 2.6 Billion in 2032.

What are Catheter-Related Bloodstream Infection Drugs?

Catheter-related bloodstream infection (CRBSI) drugs are medications used to treat infections that arise when bacteria or fungi enter the bloodstream via a central venous catheter. These drugs encompass a variety of antibiotics and antifungal agents aimed at eliminating the specific pathogens causing the infection. Initial treatment typically involves broad-spectrum antibiotics, which are then adjusted based on culture results for more precise targeting. Effective CRBSI management also includes removing or replacing the infected catheter when feasible. The primary objectives of these drugs are to eradicate the infection, prevent complications like sepsis, and allow for the continued safe use of catheters in patients requiring long-term intravenous therapy.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2388

What are the growth prospects and trends in the Catheter-Related Bloodstream Infection Drugs industry?

The catheter-related bloodstream infection (CRBSI) drugs market growth is driven by various factors and trends. The market for catheter-related bloodstream infection (CRBSI) drugs is growing due to the increasing incidence of infections linked to central venous catheters and a rising need for effective treatments. Advances in pharmaceutical research are driving the development of new antibiotics and antifungal agents tailored to combat CRBSI pathogens. Market growth is fueled by factors such as the rising prevalence of chronic conditions requiring long-term catheterization, greater awareness of infection control, and improvements in diagnostic techniques. Major contributors to the market include pharmaceutical and biotechnology companies focused on innovative therapies. Although challenges like high treatment costs and the need for targeted therapies persist, the market is expanding thanks to ongoing research and development efforts. Hence, all these factors contribute to catheter-related bloodstream infection (CRBSI) drugs market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Drug Class

Cloxacillin

Cеftazidimе

Cеfazolinе

Daptomycin

Vancomycin

Tеicoplanin

Echinocandin

Othеrs

By Routе of Administration

Oral

Injеctablе

By Indication

Bactеrial Infеctions

Fungal Infеction

Viral and Parasitic Infеctions

By Distribution Channеl

Hospital Pharmaciеs

Rеtail Pharmaciеs

Drug Storе

Onlinе Pharmaciеs

By End Usеr

Hospitals

Ambulatory Surgical Cеntеrs

Clinics

Long tеrm Carе Facilitiеs

Homе Hеalthcarе

North America

United States

Canada

Europe

Germany

United Kingdom

France

Italy

Spain

Russia

Poland

Benelux

Nordic

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

ASEAN

Australia & New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

Saudi Arabia

South Africa

United Arab Emirates

Israel

Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

Aurobindo Pharma Limitеd

Braun Mеdical Inc.

Eli Lilly and Company

Frеsеnius SE & Co. KGaA

GSK plc

Mеrck & Co. Inc.

Mylan N.V. (Viatris)

Novartis

Pfizеr Inc.

Sanofi AG

StеriMax Inc.

Tеva Pharmacеutical Industriеs Ltd.

CorMеdix

View Full Report: https://www.reportsandinsights.com/report/Catheter-Related Bloodstream Infection Drugs-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: [email protected] Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

0 notes

delveinsight12 · 7 months ago

Text

Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) Market Size & Share, Market Research Report 2032 | Companies- Citius Pharmaceuticals, CorMedix, Geistlich Pharma, TauroPharm GmbH, Fresenius Medical Care

DelveInsight’s ‘Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) -Market Insights, Epidemiology, and Market Forecast-2032’ report deliver an in-depth understanding of the catheter-related bloodstream infection, historical and forecasted epidemiology as well as the catheter-related bloodstream infection market trends in the United States, EU5, Japan, APAC, LATAM, Middle East

DelveInsight’s ‘Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) Market’ report delivers an in-depth understanding of the Catheter-Related Bloodstream Infections historical and forecasted epidemiology, market trends in the 7MM.

View full report: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market

Catheter-Related Bloodstream Infection Overview

Catheter-related bloodstream infection also known as catheter-related sepsis, defined as the presence of bacteremia originating from a catheter insertion. Antibiotics such as antibacterial and antifungal are used for the treatment of the disease. Antibiotic lock therapy is considered as adjunctive therapy in the treatment of Catheter-Related Bloodstream Infections when catheter removal is not a favorable option. The current treatment options are used as off-label therapies and only a few non-antibiotic lock solutions are approved in Europe.

Catheter-Related Bloodstream Infections Diagnosis

The diagnosis of catheter-related bloodstream infection remains a major challenge. Fever and chills that are often associated with catheter-related bloodstream infections are not specific. Furthermore, local catheter inflammation and phlebitis could exist in the absence of catheter-related bloodstream infection or even a local infection, as has been reported with peripherally inserted central catheters.

Catheter-Related Bloodstream Infections Treatment

It covers the details of conventional and current medical therapies available in the catheter-related bloodstream infection market for the treatment of the condition. It also provides the treatment guidelines and algorithms of the United States and Spain.

The DelveInsight’s catheter-related bloodstream infection market report gives a thorough understanding of catheter-related bloodstream infection by including details such as disease definition, causes, risk factors, pathogenesis, and diagnosis.

Catheter-Related Bloodstream Infections Epidemiology Key Findings

This section provides glimpses of the catheter-related bloodstream infection epidemiology in the global market.

As per DelveInsight’s analysis, the total incident population of catheter-related bloodstream infection in the 7MM was found to be approximately 4,115,000 in 2019.

Catheter-Related Bloodstream Infections Marketed Drugs

1. Neutrolin by CorMedix

2. Taurosept by Geistlich Pharma

Catheter-Related Bloodstream Infections Off-label Drugs

1. Daptomycin

2. Vancomycin

Catheter-Related Bloodstream Infections Emerging Drugs

1. Mino-Lok: Citius Pharmaceuticals

Major pharma players such as Citius Pharmaceuticals, CorMedix, Geistlich Pharma, TauroPharm GmbH, Fresenius Medical Care, and others are working in the Catheter-Related Bloodstream Infection market.

Catheter-Related Bloodstream Infections Market Outlook

The catheter-related bloodstream infection market outlook of the report helps to build a detailed comprehension of the historic, current and forecasted catheter-related bloodstream infection market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand of better technology.

According to DelveInsight, catheter-related bloodstream infection global market is expected to change in the study period 2019–2032.

Download our full report: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market

Table of contents

1 Key Insight 2 Executive Summary of Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) 3 Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) Market Overview at a Glance 4 Disease Background and Overview: Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) 5 Case Reports 6 Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) Epidemiology and Patient Population 7 United States Epidemiology 8 EU5 Epidemiology 9 Japan Epidemiology 10 Current Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) Treatment and Medical Practices 11 Unmet needs 12 Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) Marketed Drugs 13 Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) Emerging Drugs 14 Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) 7MM Market Analysis 15 United States 16 EU-5 countries: Market Outlook 17 Japan Market Outlook 18 Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) Market Drivers 19 Catheter-Related Bloodstream Infection (Catheter-Related Bloodstream Infections) Market Barriers 20 SWOT Analysis 21 Reimbursement and market access 22 Appendix 23 DelveInsight Capabilities 24 Disclaimer 25 About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Kritika Rehani

[email protected]

+91-9650213330

0 notes

vicky8588 · 2 years ago

Text

The Sick Truth of Needle-Free Iv Connectors Market

Must certainly be- Free IV Connectors Marketplace is segmented By Design Type (Simple Connectors, Complex Connectors), By Process (Positive Fluid Displacement Connectors, Adverse Fluid Displacement Connectors, Neutral Substance Displacement Connectors), and by Place (The United States, Latin America, Europe, Asia Pacific, Middle East, and Africa)– Share, Size, Prospect, and Opportunity Analysis, 2022 a significant 2029

Needle- Free IV Connectors Market Size, Share, and Growth Rate Insights

Needle a significant Free IV Connectors Market specifications were valued at around us all$ YY million in 2021 and are estimated to attain US$ YY several by 2029, growing a few CAGR of 9. 4% throughout the forecast period (2022 a substantial 2029). Intravenous (IV) access and drug administration are crucial although risky procedures with several conceivable problems during and post a significant IV access from Needle-free IV fittings are to reduce the system. most serious problems and help with patient compliance. Must certainly be free IV connectors website link syringes, administration sets, and 4 catheters. The use of dealing with needle-free IV fittings, aside from infusion, is to reduce associated with a needle substantial stick injuries among healthcare services and decrease the chance of bacterial and microbial contamination.

Must certainly be free IV connectors market study analysis provides a thorough- depth outlook available composed of quantitative and qualitative data. The idea gives an outlook of the global market established on market segmentation. It even provides global Needle- no cost IV connectors market size, and growth, along with the most up-to-date trends, opportunities, and forecasts until finally 2029 for the global marketplace with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Empire, Russia, European countries, United Arabic Emirates, Saudi Arabia, South the African continent, Japan, China, India, South Korea, Australia, and rest of the countries in the globe.

Among every region, the United States region can be expected to hold the most important share of the global marketplace in the forecast period. The most for example - the free IV connectors marketplace in America and Canada produces the most share. Whereas the American Needle-free IV fittings market is projected to continue its existence globally over 2022- 2029.

Download Free Sample: https://www.datamintelligence.com/download-sample/needle-free-iv-connectors-market

Needle- No cost IV Connectors Market Growth Owners, and Dynamics

The global as an example - free IV connectors marketplace is mainly driven by the developing possibility of life-threatening disorders associated with bloodstream infections and the increasing prevalence of several chronic diseases.

Rising standards for anti-reflux technology for needleless connectors are expected to drive market growth.

According to Nexus Medical, manufacturers with the Nexus TKO- 6P Anti a considerable Reflux connector, the Infusion Rns Society(INS) provided help with the utilization of needleless connectors with anti a considerable reflux technology in its not too long ago publication under 2021 Infusion Treatment method Standards of Practice. The current Standards, INS 'most known publication, define specific categories from needleless connector technology based on the device's internal mechanism of fluid displacement, negative displacement, excellent displacement, neutral, and anti-considerable reflux. Anti-reflux needleless connectors cause the smallest amount of level of blood reflux, which could well be related to various catheter-related conditions that risk patient safety, such as catheter failure, intraluminal thrombotic occlusions, and also infections. For instance, The Nexus TKO anti-reflux connector showcases a pressure of a considerably activated

diaphragm that controls material movement, eliminating unintentional blood reflux caused by internal and alternative pressure changes. This has been demonstrated to produce the least amount of blood reflux compared to any other needleless connector.

Moreover, the Nexus TKO prevents blood reflux while reducing variation and streamlining the complexity of IV treatment solutions. Most needleless connectors require precise flushing, clamping, and disconnection sequences to minimize blood reflux. For comparison, the Nexus TKO quickly provides bidirectional flow control, steering free from blood reflux because of immediate pressure changes and eliminating the benefits of user-cantered clamping sequences. Thus, to sum up - mentioned factor, the industry is likely to have a disk drive, to sum, the forecast period.

Increasing solution recalls for the needle-zero cost IV connectors are anticipated to hamper growth.

For instance, on January 9, 2020, Fda recalled Baxter Healthcare Corporation's Category 2 Device ONELINK Needle as a significant free IV Connector since it is Continue- Flo sets with male Luer bodies at the reduced finish of, and in just, the ISO specification for outside diameter requires a better instead of expected connection force to completely inset and securely tighten the Luer on usually the one- Web site LINK connector. The producer has initiated the recall, but only some merchandise has now been removed and customized. Thus, from the above considerable mentioned factors, the market can be expected to hamper the outlook period.

COVID- 19 Effects Analysis

The COVID-19 pandemic has negatively impacted the needle-free IV fittings market. The COVID-19 pandemic has considerably increased hospital workloads worldwide, and many patients include required extended hospital stays, including admissions to intensive care products (ICUs). Care for these people was provided under difficult circumstances, not only due to raised workload but also because generally there was sometimes a need to involve staff with an inadequate workout with ICU patients. Moreover, catheter-related bloodstream infection can certainly result from bacterial contamination from intravascular catheter infusion hubs from the critically ill. Intravascular catheter entrance ports are frequently contaminated with bacteria before bloodstream infections arise. Such contaminations occur during the connection of intravascular line fittings for infusions, drug injections, as well as blood sample withdrawal. Because of the increased frequency of infusion connections and disconnections, multivolume catheters are especially vulnerable to disease. Therefore, this has been proposed that as an example - free connectors (NFC) lower the rate of toxic bacterial contamination and subsequent catheter-affiliated bloodstream infection (CRBSI).

On the other hand, marketplace players have reduced investment in raw materials and resources as a result of the closure of manufacturing establishments to shield employees in all parts. Thus, to sum up, the considerably mentioned factors, the market became affected. However, the situation can be supposed to improve progressively in the forecast period.

Segment Examination

Neutral fluid displacement connector’s part is supposed to hold the most important market share in needle a considerable free IV connectors

The basic fluid displacement connectors segment paid for the biggest market talk about in 2021. The segment features a smooth nasal septum surface with a swappable top rate that can be thoroughly disinfected, a tight seal between nasal septum and housing, an aligned, low-tortuous fluid path, some minimum residual volume, and housing to visualize flushing. For instance, B. Braun Medical Incorporation., In Vision- Plus Neutral Shift Needleless Connectors with

Neutral Benefits Technology is created to inhibit the page of bacteria into the substance pathway, potentially enhancing patient effects and improving clinician safety. The idea is a neutral fluid shift needleless IV connector that combines septum seal integrity and some double microbial barrier. It features a simple internal cannula layout with no moving parts just the fluid pathway. Thus, via the above factors, the market segment made up the most important market share in the predicted period.

Geographical Analysis

Southwest America region holds the most important market share in the world - wide needle- Free IV furnishing

North American region is paid for the most important market share for 2021. The usage increasing prevalence of healthcare-associated catheters substantially related to bloodstream infection (HA a substantial BSIs), awareness about the usage of for example - free IV connectors among people, the rising geriatric inhabitants, and the presence of essential players in your community are the factors drive a vehicle the market in your community forecast period. As an illustration, based on the National Selection of drugs Report 2022, a great estimated 250, 000 bloodstream bacterial contamination occur each year, most affiliated with intravascular devices. The CLABSI rate in intensive care products (ICU) in the US can be estimated as being 0. 8 every 1000 mainline days. For that reason, there is a rise in demand for needles and considerably free IV connectors in the region. Moreover, On May one particular, 2019, B. Braun signed a distribution agreement with Nexus Medical, LLC for its Nexus TKO- 6P Luer Activated Anti-- Reflux Device in the United States. As a result, from the above-stated factors, North American place is made up the most important market share in the predicted period.

competitive landscape

Major essential players in the needle considerable free IV connectors market happen to be BD, CareFusion Corporation, Baxter Foreign Inc., B. Braun Melsungen AKTIENGESELLSCHAFT, Vygon SA, Cardinal Health, ICU Medical Inc., Nexus Medical LLC, RyMed Technologies LLC, and NP Medical Inc.

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

0 notes

healthcare-market · 3 years ago

Text

Dual Chamber Prefilled Syringes Market Size, Share, Growth Trends, and Forecast Analysis

Dual Chamber Prefilled Syringes Market: Overview

Dual chamber prefilled syringes are extensively used in infusion therapy for dual purposes intravenous drug administration and flushing chambers. Existing patents allow for only sequential use. Evolving standards of care in infusion therapy have paved way for continuous design advances in vascular access device (VAD), with the safety and efficacy of dual chamber prefilled syringes garnering attention. Growing use of peripheral intravenous catheter (PIVC) in infusion therapy for administering drugs and blood products is a key trend bolstering the expansion opportunities for manufacturers in dual chamber prefilled syringes market. Key forms are liquid/liquid and liquid/powder. Key focus of manufacturers is to manage common catheter-related complications, reduce contamination risks, and also reduce procedural times. Expanding patents has led to improvements in the safety of dual chamber prefilled syringes.

Read Report Overview: https://www.transparencymarketresearch.com/dual-chamber-prefilled-syringes-market.html

Dual chamber prefilled syringes are used in a wide range of indications some of which are hemophilia, schizophrenia, endometriosis, erectile dysfunction, and diabetes. The study on the dual chamber prefilled syringes market makes a critical analysis of major product developments, research avenues, degree of concentration of key players, key forces of market, and supply and demand analysis. The various insights offer assessment of market opportunities in various end-use segments and their shares in the global dual chamber prefilled syringes market.

Request a Sample of Dual Chamber Prefilled Syringes Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=80231

Dual Chamber Prefilled Syringes Market: Key Trends

The drive for improving the outcomes of intravenous therapeutics and flushing in infusion therapy is a key trend boosting the growth of the dual chamber prefilled syringes market. Over the past years, there has been substantial rise in number of patients with PIVC experiencing catheter-related complications, phlebitis, and bloodstream infections. Updating of guidelines and standards of care have helped in the evolution of the dual chamber prefilled syringes market. However, the rate of launch of such syringes is relatively low. Particularly, industry players are expected to benefit from the need to develop syringes that allow sequential use of the flushing chamber for pre- and post-intravenous procedure.

Enquiry Before Buying Dual Chamber Prefilled Syringes Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=80231

Also, the literature lacks due to which there is lack of definite information to healthcare professionals and providers. Further, there is an urgent need for making the technology cost-effective for adoption. Nevertheless, strides made in biopharmaceutical industry are bolstering the growth of the dual chamber prefilled syringes market.

Request For Discount - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=80231

Dual Chamber Prefilled Syringes Market: Competitive Analysis and Key Developments

A number of clinical studies have been done with an aim to test the advantage of dula chamber prefilled syringes over classic syringes in peripheral intravenous drug administration and catheter flushing. One such study was performed by researchers from Portugal. As many 146 adult patients were part of multi-center, two-arm randomized controlled trials. The aim of the study was to develop guidelines for nurses handling intravenous procedures. The effectiveness and safety was thoroughly tested. The incidence of nosocomial bacteraemia in PIVC was one of the several catheter-related complications that were tested. Such studies will help develop inexpensive devices in the dual chamber prefilled syringes. A number of manufacturers are testing new materials in the making of the syringes, most prominent of which is glass.

Pre-Book Dual Chamber Prefilled Syringes Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=80231&ltype=S

Dual Chamber Prefilled Syringes Market: Regional Assessment

Some of the key regions in the dual chamber prefilled syringes market are North America, Asia, and Europe. North America and Europe are promising markets. A large part of the demand comes from clinical role of these syringes in managing patients with hemophilia. North America has been a substantially lucrative market, with manufacturers expanding their production capacities. Rise in awareness about catheter-related infections in the healthcare systems in Asia is also fueling the avenues for manufacturers in the dual chamber prefilled syringes market.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/technological-advancements-and-innovations-to-fuel-growth-of-soft-tissue-repair-market-from-2018-to-2026-tmr-301168624.html

https://www.prnewswire.com/news-releases/increase-in-demand-for-new-therapies-for-effective-management-to-drive-global-menopausal-hot-flashes-treatment-market-says-tmr-301378552.html

https://www.prnewswire.com/news-releases/global-oral-contraceptive-pills-market-projected-to-expand-at-6-cagr-rising-number-of-unplanned-pregnancies-drives-market-demand-tmr-301171827.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

0 notes

jesse-pinkman123 · 3 years ago

Text

Clot Management Devices Market Size, Trends, Shares, Insights and Forecast – 2018-2026

Global Clot Management Devices Market Regional Analysis

North America is expected to hold a dominant position in the global Clot Management Devices Market over the forecast period, owing to frequent research and development activities in the region.

For instance, in April 2019, Tufts Medical Center in Boston and Eskenazi Health, a partner with the Indiana University School of Medicine, are developing a Mobile Active Compression (MAC) calf device for prevention of deep vein thrombosis. MAC is light-weight and portable device, which can be worn around limbs, as limbs have higher risk of deep vein thrombosis. Such innovations associated with clot management devices are expected to accelerate the global clot management devices market growth.

Blood clot is usually a response to the injury so as to prevent infection and minimize the blood flow. Embolus is a part of blood-clotting, which separates from the site of thrombus and circulate through bloodstream into the body. It can obstruct the function of blood vessels and thus leading to harmful effects in the body. High cholesterol, heavy weight of body, diabetes, cancer, and sedentary lifestyle can be a cause for clotting of blood in the body. These blood clots can be treated by medications such as anti-coagulants, compression stockings, surgery, stents, and vena cava filter. These treatments prevent from formation of more blood clots in the body.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2650

Global Clot Management Devices Market Drivers

Approval and launch of the novel clot management devices are expected to boost the global clot management devices market. For instance, in May 2019, the U.S. Food and Drug Administration (FDA) approved Bashir Endovascular Catheter (BEC) and Bashir N-X endovascular catheter (BEC N-X) developed by a scientist from Temple University Hospital in Philadelphia, Pennsylvania and is being commercialized by Thrombolex, Inc. BEC received approval for its controlled infusion of fluids (thrombolytics) in peripheral vasculature and BEC N-X is being used for controlled infusion of fluids into pulmonary and peripheral vasculature.

Furthermore, key players are also trying to expand the indications of its already approved products. For instance, in February 2018, the U.S. FDA expanded indications for Trevo clot retriever, a device designed by Stryker Corporations. Trevo Retriever is the first thrombectomy device to receive approval for expansion by 18 hours of treatment time for acute ischemic stroke. Originally Trevo clot retriever had been approved in 2012. Such frequent approvals by the U.S. FDA is expected to drive the global clot management device market growth.

Furthermore, activities such as collaborations, partnerships, merger, and acquisitions of the manufacturers are expected to drive the global clot management devices market growth. For instance, in September 2018, LeMaitre Vascular Corporation acquired vascular clot management business of Applied Medical Resources Corporation. The parties had undergone an agreement of transitional services, where Applied Medical Resources Corporation was supposed to manufacture its clot management product line for LeMaitre Vascular Corporation. This factor is expected to have a positive influence on the global clot management devices market growth over the forecast period.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/clot-management-devices-market-2650

Global Clot Management Devices Market Restraints

High cost of clot management devices is expected to hamper the global clot management devices market growth over the forecast period. For instance, according to the data published by National Center for Biotechnology Information (NCBI) in 2016, the cost of 5MAX ACE catheter, used for the extraction of clots in ischemic stroke was around US$ 4,916. Hence, high cost may lead to lesser adoption of devices and thereby, hindering the global clot management devices market growth.

Global Clot Management Devices Market Key Players

Some of the major players operating in the global clot management devices market include Edward Lifesciences Corporation, Straub Medical AG, Boston Scientific Corporation, Medtronic, Inc., Volcano Corporation, LeMaitre Vascular, Inc., Teleflex Inc., Argon Medical, Stryker Corporation, and Angiodynamics.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2650

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

mailto:[email protected]

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

#Clot Management Devices Market Share #Clot Management Devices Market

0 notes

kritikarehani · 4 years ago

Text

Catheter-Related Bloodstream Infection (CRBSI) Market Research Report 2030 by DelveInsight

DelveInsight’s ‘Catheter-Related Bloodstream Infection (CRBSI) Market’ report delivers an in-depth understanding of the CRBSI historical and forecasted epidemiology, market trends in the geographies listed below.

Geographies Covered:

The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, APAC (China, India, Taiwan, South Korea, and Australia), LATAM (Brazil, Mexico, Argentina, and Colombia), Middle East (Saudi Arabia and the United Arab Emirates) and Russia

View full report: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market

Catheter-Related Bloodstream Infection: Disease Understanding and Treatment Algorithm

Catheter-Related Bloodstream Infection Overview

Catheter-related bloodstream infection also known as catheter-related sepsis, defined as the presence of bacteremia originating from a catheter insertion. Antibiotics such as antibacterial and antifungal are used for the treatment of the disease. Antibiotic lock therapy is considered as adjunctive therapy in the treatment of CRBSI when catheter removal is not a favorable option. The current treatment options are used as off-label therapies and only a few non-antibiotic lock solutions are approved in Europe.

CRBSI Diagnosis

CRBSI Treatment

CRBSI Epidemiology

The CRBSI epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by total incident population of CRBSI total diagnosed incident population of Catheter-Related Bloodstream Infection, and Diagnosed Incidence of Catheter-Related Bloodstream Infection by Causative Pathogens scenario of catheter-related bloodstream infection in the global market.

Key Findings

This section provides glimpses of the catheter-related bloodstream infection epidemiology in the global market.

· As per DelveInsight’s analysis, the total incident population of catheter-related bloodstream infection in the global market was found to be 4,114,882 in 2017. The estimates show a higher incidence of catheter-related bloodstream infection in India with 1,722,280 cases in 2017.

Download epidemiology insights of the report: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infections-crbsis-epidemiology-forecast

CRBSI Marketed Drugs

· Neutrolin by CorMedix

· Taurosept by Geistlich Pharma

CRBSI Off-label Drugs

· Daptomycin

· Vancomycin

CRBSI Emerging Drugs

· Mino-Lok: Citius Pharmaceuticals

Request for our sample report: https://www.delveinsight.com/sample-request/catheter-related-bloodstream-infection-market

CRBSI Market Outlook

According to DelveInsight, catheter-related bloodstream infection global market is expected to change in the study period 2017–2030.

Key Findings

· This section includes a glimpse of the catheter-related bloodstream infection global market. The market size of CRBSI in the Global market was USD 1,237.38 million in 2017.

Download our full report: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market

0 notes

shweta2707 · 4 years ago

Text

Central Venous Catheter Market Drivers, Opportunities, Industry Analysis and forecast till 2027

Summary:

A central venous catheter is a long, thin, flexible tube placed into the large vein near the heart. It reaches the large vein through internal jugular vein, subclavian vein or femoral vein. Central access catheters are used to for administering medicines, fluids, nutrients, blood and blood products.

The global Central Venous Catheter Market is estimated to account for US$ 778.0 Mn in terms of value in 2019 and is expected to reach US$ 1,164.5 Mn by the end of 2027.

Market Drivers

Increasing prevalence of diseases that require long-term therapies such as cancer (chemotherapy) and end stage renal disease (dialysis) is expected to fuel growth of the U.S. central venous catheter market. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018.

Moreover, high incidence of renal diseases is also expected to aid in the market growth. For instance, according to European Renal Association – European Dialysis and Transplant Association’s data in 2018, over 850 million people worldwide have some form of kidney disease.

Statistics:

Asia Pacific region held dominant position in the global central venous catheter market in 2018, accounting for 30.1% share in terms of value, followed by North America.

Request for the Sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/2400

Market Opportunities

Introduction of catheters with antimicrobial protection is expected to offer lucrative growth opportunities for players in the global central venous catheters market. For instance, in July 2019, researchers from Nottingham University reported development of a Bactigon, a new family of biomaterials that have a major impact against antimicrobial resistance (AMR).

Major regulatory bodies are focused on offering guidance for product approval, which is expected to offer lucrative growth opportunities for players in the market. For instance, in January 2020, the U.S. FDA released draft guidance detailing the information device-makers should include in 510(k) submissions of catheter-based devices intended to treat peripheral vasculature lesions.

Market Trends

The use of evidence-based care bundles reinforced by real-time feedback has led to significant decrease in rate of catheter-related bloodstream infection in the intensive care unit.

The use of central venous catheter in administering chemotherapy drugs has increased significantly. This is owing to various benefits of central venous catheters such it helps to avoid serious damage to skin and muscle tissue from drugs that are capable of such adverse effects if they leak outside a vein.

Request for the PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2400

Regulations

U.S.

The U.S. FDA authorized use of mono, duo, trio, Quattro lumen central venous catheters, as they fall under class II

Therefore, companies do not require a premarket approval before commercializing the device for central access procedures. However, a 510K approval is still necessary

According to the Federal Food, Drug and Cosmetic Act (Act), central venous catheters comes under class II and do not require approval i.e. premarket approval application (PMA). However the device is marketed under general controls provisions of the Act. which includes requirements for annual registration, listing of devices, good manufacturing practice, labeling and prohibitions against misbranding and adulteration.

Value Chain Analysis

Major players operating in the global Central Venous Catheter Market include,

AngioDynamics, C.R. Bard, Teleflex Incorporated, B. Braun Melsungen AG, Kimal, Comed B.V., Medtronic Plc., Smiths Medical, Inc., and Vygon Group.

About Us

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

Customized Market Research Services

Industry Analysis Services

Business Consulting Services

Market Intelligence Services

Long term Engagement Model

Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt.Ltd.

Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

Phone: +1–206–701–6702

Email: [email protected]

#central venous catheter market #coherent market insights #market research #market analysis #business consulting

0 notes

healthcare00897 · 5 years ago

Text

Antimicrobial Catheter Market Size, Share, Demands and Gross Margin 2026

Antimicrobial catheters are designed to protect patients from hospital acquired urinary tract infections (UTIs). Hospital-acquired or nosocomial urinary tract infections are initiated by using urinary catheters, which are inserted in urinary tract during the treatment of hospitalized patients. In case of urinary tract infection, which is associated with the catheters, the bacteria travel up to the bladder and cause infection. Most of the urinary tract infections occur due to the use of catheters made with non-ideal material. Use of non-ideal material can lead to colonization of microorganisms, which results into bacteriuria and infection. However, to overcome infections related to catheters, manufacturers are focusing on development of antimicrobial catheters with materials that are biocompatible, antimicrobial, and antifouling.

Get Exclusive Sample Report at: http://bit.ly/31OUaqh

Antimicrobial Catheter Market – Drivers

Increasing initiatives by research firms to develop safe-to-use catheters is expected to increase the antimicrobial catheter market share. For instance, in March 2019, researcher at Brown University announced the development of a new antibacterial coating for intravascular catheters, which is expected to prevent catheter-related bloodstream infections, the most common type of hospital-acquired infections.

Increasing incidences of Catheter Associated Urinary Tract Infections (CAUTI) is expected to boost growth of the antimicrobial catheter market. For instance, in April 2015, according to the research study results For Catheter Associated Urinary Tract Infection (CAUTI) And Antibiotics Sensitivity Pattern from Confirmed Cases of CAUTI in Tertiary Care Hospitals, published in Clinical Microbiological journal, out of 1380 catheterized patients, 34 developed CAUTI. The overall incidence was 4.59 per 1000 catheter days.

Antimicrobial Catheter Market- Restraints

However, product recall for antimicrobial catheters is a major issue, which is hampering the antimicrobial catheter market growth. For instance, in October 2018, the U.S. Food and Drug Administration (FDA) issued a product recall notices to Rochester Medical Corp. to recall its Magic3 Antibacterial Hydrophilic Intermittent Catheter, owing to misbranding (mislabeling) of the product. The product was labeled as an Antibacterial Hydrophilic Intermittent Catheter instead of an Antibacterial Intermittent Catheter (no hydrophilic coating).

Antimicrobial Catheter Market- Regional Analysis

On the basis of region, the global antimicrobial catheter market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to witness significant growth over the forecast period, owing to increasing cases of CAUTIs in the region. For instance, in June 2016, according to report published in Modern Healthcare, CAUTIs were a major cause of hospital-acquired infection in the US and incidences of these infections have increased in the recent past.

Furthermore, Europe is expected to witness significant growth in the market, owing to increasing product launches in this region. For instance, in April 2018, a urinary catheter coated with new bacteria resistant materials, developed by the University of Nottingham, received CE marking for use by hospitals in the U.K. and other countries in Europe. The devices were trialed in 6 hospitals across the U.K.

Ask For Discount Before Purchasing This Business Report @ http://bit.ly/2X0MUnR

Antimicrobial Catheter Market- Key Players

Key players operating in the antimicrobial catheter market include, C. R. Bard, Medtronic Plc., B. Braun Melsungen AG, Cook Medical, and Teleflex Incorporated.

Antimicrobial Catheter Market- Taxonomy

By Catheter Type

Central Venous Catheters

Urinary Catheters

By Material Type

Silver Alloys Catheters

Nitrofural-impregnated Catheters

By End User

Hospitals

Ambulatory Surgical Centers

Clinics

Others

By Region

North America

Europe

Asia Pacific

Latin America

Middle East

Africa

About Coherent Market Insights

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: [email protected]

0 notes

businessindustry · 4 months ago

Text

Catheter-Related Bloodstream Infection Drugs Market Overview and Future News by 2032

The Reports and Insights, a leading market research company, has recently releases report titled “Catheter-Related Bloodstream Infection Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Catheter-Related Bloodstream Infection Drugs Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Catheter-Related Bloodstream Infection Drugs Market?

What are Catheter-Related Bloodstream Infection Drugs?

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2388

What are the growth prospects and trends in the Catheter-Related Bloodstream Infection Drugs industry?

What is included in market segmentation?

The report has segmented the market into the following categories:

By Drug Class

Cloxacillin

Cеftazidimе

Cеfazolinе

Daptomycin

Vancomycin

Tеicoplanin

Echinocandin

Othеrs

By Routе of Administration

Oral

Injеctablе

By Indication

Bactеrial Infеctions

Fungal Infеction

Viral and Parasitic Infеctions

By Distribution Channеl

Hospital Pharmaciеs

Rеtail Pharmaciеs

Drug Storе

Onlinе Pharmaciеs

By End Usеr

Hospitals

Ambulatory Surgical Cеntеrs

Clinics

Long tеrm Carе Facilitiеs

Homе Hеalthcarе

North America

United States

Canada

Europe

Germany

United Kingdom

France

Italy

Spain

Russia

Poland

Benelux

Nordic

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

ASEAN

Australia & New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

Saudi Arabia

South Africa

United Arab Emirates

Israel

Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

Aurobindo Pharma Limitеd

Braun Mеdical Inc.

Eli Lilly and Company

Frеsеnius SE & Co. KGaA

GSK plc

Mеrck & Co. Inc.

Mylan N.V. (Viatris)

Novartis

Pfizеr Inc.

Sanofi AG

StеriMax Inc.

Tеva Pharmacеutical Industriеs Ltd.

CorMеdix

View Full Report: https://www.reportsandinsights.com/report/Catheter-Related Bloodstream Infection Drugs-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

0 notes

rohinic123-blog · 4 years ago

Text

Catheter-related Bloodstream Infections Market to Reap Excessive Revenues by 2030

Catheter-related Bloodstream Infections Market: Introduction

Catheter-related bloodstream infections occur due to presence of bacteremia. It is one of the most frequent, lethal, and costly complications of central venous catheterization and the most common cause of nosocomial bacteremia. It is caused due to an intravascular catheter by quantitative culture of the catheter tip or by differences in growth between catheter and peripheral venipuncture blood culture specimens.

Report Overview @

http://www.transparencymarketresearch.com/catheter-related-bloodstream-infections-market.html

Patient-related factors such as presence of distant infection, compromised integrity of the skin, granulocytopenia, and severity of illness increase the risk of bloodstream infection

Key Drivers and Opportunities of Global Catheter-related Bloodstream Infections Market

Rise in prevalence of bloodstream infection is projected to drive the global market. An article published in Continuing Education in Anaesthesia, Critical Care & Pain stated that catheter-related bloodstream infections occur in ~3% of catheterizations; however, the incidence could be as high as 16%.

Serious effects associated with inaccurate diagnoses, such as procedural complications, lead to increase in morbidity and mortality. Hence, it is essential to make an accurate diagnosis of catheter-related bloodstream infections.

Planning To Lay Down Future Strategy? Request Brochure Of Catheter-related Bloodstream Infections Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77630

Moreover, hospital-acquired infection increases the risk of CRBSI. According to the International Journal of Critical Illness and Injury Science, CRBSI accounts for 10% to 20% of hospital-acquired infections in the U.K.

Governments in developing countries are making significant investments toward modernization of health care infrastructure, which is likely to increase access to health care. Moreover, health care-acquired infection is a major issue in developing countries. Hence, increase in demand for the products owing to surge in patient population presents significant opportunity in the global market.

North America to Capture Major Share of Global Catheter-related Bloodstream Infections Market

North America is projected to account for major share of the global catheter-related bloodstream infections market during the forecast period due to well-established health care infrastructure. Europe is anticipated to be the second largest market from 2020 to 2030.

The catheter-related bloodstream infections market in Asia Pacific is expected to grow at a rapid pace during the forecast period owing to rise in prevalence of hospital-acquired infections. According to the World Health Organization Department of Communicable Disease, the risk of health care-associated infection is 2 to 20 times higher in developing countries than in developed countries.

To Obtain All-Inclusive Information On Forecast Analysis Of Catheter-related Bloodstream Infections Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77630

Key Players Operating in Global Catheter-related Bloodstream Infections Market

The global catheter-related bloodstream infections market is highly consolidated due to the presence of small number of key players. These players hold major share in their respective regions. Demand for catheter-related bloodstream infections products has increased in emerging as well as developed markets owing to rise in prevalence of blood stream infections. Growth strategies and focus on research & development by key players are the factors likely to drive the global catheter-related bloodstream infections market. For instance, in February 2020, CorMedix, Inc. announced that Neutrolin received grant from the U.S. Food and Drug Administration for the prevention of catheter-related blood stream infections (CRBSIs) in hemodialysis patients.

Request For Covid19 Impact Analysis –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77630

More Trending Reports by Transparency Market Research –

Radiopharmaceutical Market -

https://www.prnewswire.com/news-releases/radiopharmaceutical-market-to-reach-valuation-of-us-5-4-bn-by-2027-transparency-market-research-301018881.html

Glycated Hemoglobin Testing Market –

https://www.biospace.com/article/glycated-hemoglobin-testing-market-point-of-care-segment-to-dominate-the-other-test-segments-in-the-global-market/

0 notes

vicky8588 · 3 years ago

Text

Central Vascular Access Devices Market Size Share and Industry Outlook to 2028

Global Central Vascular Access Devices Market is segmented By Type (Peripheral Inserted Central Catheter, Non-tunneled Catheters, Tunneled Catheters, Implanted Ports), By Application (Drug administration, Parenteral Nutrition, Chemotherapy, Blood transfusion, Diagnostics & Testing), By End User (Hospital, Clinics, Ambulatory Surgery Centres), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Global Central Vascular Access Devices market is growing at a CAGR of 7%.during the forecast period (2021-2028).

Central venous access devices (CVAD), also referred to as venous access ports or catheters are thin, hollow, flexible tubes placed in large veins of patients to allow frequent access to threads in the bloodstream.

These devices are inserted either by surgeons or interventional radiologists with or without the use of general anesthesia.

Download Free Sample: https://www.datamintelligence.com/download-sample/central-vascular-access-devices-market

Market Growth

Primary market drivers include the rise in acute and chronic diseases such as systemic infections as well as increasing the use of vascular access devices in pediatric patients.

However, the risk of catheter-related complications, the high costs involved in the placement and maintenance of these devices, the high rate of product recalls and failures will restrict the market growth.

Market Segmentation

Global Central Vascular Access Devices market report segments the market by type, by application, and by region.

Based on the type, the market is categorized into four major categories: Peripheral Inserted Central Catheter, Non-tunneled Catheters, Tunneled Catheters, and Implanted Ports.

Based on application, the market is segmented into Drug administration, Parenteral Nutrition, Chemotherapy, Blood transfusion, and Diagnostics & Testing.

Regionally, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW.

North America accounted for the largest market share in 2017.

It is expected to remain dominant throughout the forecast period owing to the increasing usage of CVADs.

There are over 5 million CVADs inserted every year in the US.

Key Segments covered

By Type

· Peripheral Inserted Central Catheter

· Non-tunneled Catheters

· Tunneled Catheters

· Implanted Ports

By Application

· Drug administration

· Parenteral Nutrition

· Chemotherapy

· Blood transfusion

· Diagnostics & Testing

By End-User

· Hospital

· Clinics

· Ambulatory Surgical Centre

By Region

· Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)

· Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)

· North America (The USA, Canada, Mexico)

· South America (Brazil, Argentina, Rest of South America)

· Rest of the World

Companies Profiled in the report :

The report also profiles the following companies in the Central Vascular Access Devices market – AngioDynamics, B.Braun Medical, C.R. Bard, Teleflex, Vygon, and so on.

Why purchase the report?

Visualize the composition of the Central Vascular Access Devices market across each indication, regarding type and treatment options, highlighting the key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of the market – level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for key Central Vascular Access Devices of all major market players

Target Audience

· Equipment Suppliers/ Buyers

· Service Providers/ Buyers

· Industry Investors/Investment Bankers

· Education & Research Institutes

· Research Professionals

· Emerging Companies

· Manufacturers

Trending Topics

· Central Vascular Access Devices Market

· Central Venous Catheters Market

· Ventricular Assist Devices Market

About Us

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

#medicaldevices #cardiovascular devices

0 notes

healthcare-market · 3 years ago

Text

Dual Chamber Prefilled Syringes Market Shares, Strategies and Opportunities 2025

Dual Chamber Prefilled Syringes Market: Overview

Request a Sample of Dual Chamber Prefilled Syringes Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=80231

Enquiry Before Buying Dual Chamber Prefilled Syringes Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=80231

Dual Chamber Prefilled Syringes Market: Key Trends

Request For Discount - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=80231

Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=80231

Dual Chamber Prefilled Syringes Market: Competitive Analysis and Key Developments

Pre-Book Dual Chamber Prefilled Syringes Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=80231&ltype=S

Dual Chamber Prefilled Syringes Market: Regional Assessment

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/technological-advancements-and-innovations-to-fuel-growth-of-soft-tissue-repair-market-from-2018-to-2026-tmr-301168624.html

https://www.prnewswire.com/news-releases/global-oral-contraceptive-pills-market-projected-to-expand-at-6-cagr-rising-number-of-unplanned-pregnancies-drives-market-demand-tmr-301171827.html

About Us

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

0 notes

pragya1-blog · 6 years ago

Text

Advanced Parenteral Drug Delivery Devices Market: Analysis and Research Report by Experts 2025

Parenteral drug delivery devices are used for administration of drugs by routes other than the oral mode of dosage. Technological advancement in the area of parenteral drug delivery systems has led to development of innovative devices that enable sophisticated mode of drug targeting and controlled release of parenteral medicines. Parenteral formulations especially intravenous, allows direct access of the drug into the bloodstream and rapid onset of drug action at specific target sites. Parenteral drug delivery systems offers benefits over other dosage forms for drug delivery in critical medical conditions such as nausea, unconsciousness, and during clinical emergency conditions. Parenteral drug delivery systems are efficient in delivery of active drug molecule with poor bioavailability and drugs with narrow therapeutics index.

Obtain Report Details @

https://www.transparencymarketresearch.com/advanced-parenteral-drug-delivery-devices-market.html

Parenteral route of drug delivery offers advantages of speedy onset of drug action. Maintenance of effective drug concentration range of systemic drugs is mandatory for effective treatment. This is achieved by repeated injections, which causes discomfort among patients. Thus, key players are investing in development of novel drug delivery systems which could reduce the patient discomfort level. Parenteral drug delivery devices optimizes the therapeutics index of drugs by providing immediate drug action in systemic level in the desired quantity for treatment. Growing prevalence of cardiac diseases, diabetes, and cancer are the major factors augmenting the growth of the advanced parenteral drug delivery devices market. Rising investment from key players for development of novel mode of administration of new drugs is likely to drive the market growth of advanced parenteral drug delivery devices.

Enquiry for Discount on this Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=390

The global advanced parenteral drug delivery devices market can be segmented based on product type, application, end-user, and region. In terms of product type, the global advanced parenteral drug delivery devices market has been segmented into prefillable syringes, injectors cartridges, hypodermic syringes, IV catheters, and others. In terms of applications, the market has been segregated into central nervous system agents, respiratory agents, hormones & related agents, gastrointestinal agents, cardiovascular agents, anti-infective agents, nutritional agents, and genito-urinary agents. In terms of end-user, the market can be segmented into hospitals, clinics, and diagnostic centers, ambulatory surgical centers and others.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=390

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The companyâ€™s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMRâ€™s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Transparency Market Research State Tower, 90 State Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected] Website: www.transparencymarketresearch.com

#Advanced Parenteral Drug Delivery Devices Market

0 notes

jesse-pinkman123 · 3 years ago

Text

Antimicrobial Catheter Market Size, Trends, Shares, Insights and Forecast – 2018-2026

Antimicrobial Catheter Market- Regional Analysis

On the basis of region, the global Antimicrobial Catheter Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2708

Antimicrobial Catheter Market – Drivers

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/antimicrobial-catheter-market-2708

Antimicrobial Catheter Market- Restraints

Antimicrobial Catheter Market- Key Players

Key players operating in the antimicrobial catheter market include, C. R. Bard, Medtronic Plc., B. Braun Melsungen AG, Cook Medical, and Teleflex Incorporated.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2708

About Coherent Market Insights:

mailto:[email protected]

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

#Antimicrobial Catheter Market Analysis #Antimicrobial Catheter Market

0 notes

healthcaremarket242-blog · 6 years ago

Text

Global Needle-free IV Connectors Market Analysis based on Healthcare Applications 2026

Needle-Free IV Connectors are routinely used in the hospitals for intravenous administration of fluids and medicines to protect the hubs in vascular access systems. In order to reduce risks of possible contaminations associated with the IV administration and to curb manipulation as much as possible, needle free IV connectors can prove to be ideal in all types of IV infusions. Furthermore, technological advancements such as connectors that prevent fluid reflux, highly closed systems, and connectors embedded with antimicrobial agents (V-Link) have helped to decrease the risk of bloodstream infections associated with IV administration. Needle-free connectors are with extended dwell time that can help preventing intraluminal contamination and device cross-contamination, which can be favorable for the growth of the market in the near future.

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/426

Market Dynamics

Government organizations and regulatory bodies namely Centers for Disease Control and prevention (CDC) have recommended the usage of needle-free connectors to reduce the incidence of sharp injuries and blood stream infections mandating its usage in medical facilities in the ‘Guidelines for the Prevention of Intravascular Catheter-Related Infections’ in 2011. Major issues associated with the conventional options of intravenous infusion are contamination from external sources during administration, blood reflux, and risk of bloodstream infections, which are addressed by needle-free IV connectors. The National Healthcare Safety Network (NHSN) conducts various programs worldwide that helps to impart education and hands on training sessions to all physicians and nurses about the usage of needle-free connectors and insertion of central venous catheters in children and adults. The advantages of needle-free IV connectors over conventional IV administration namely, safer access to IV lines without using needle, reduced risk of bloodstream infections and reduced possibility of contamination, rising chronic diseases prevalence and cost containment through use of needle-free IV connectors is expected to boost the growth of needle-free IV connectors market over the forecast period.

Some major players operating in the needle-free IV connectors market are Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA.

Market Taxonomy

This report segments the global IV Connectors (Needle-free) market on the basis of design type, mechanism, and dwell time. On the basis of design type, the global needle-free IV connectors market is segmented into Simple and Complex. Mechanisms of needle-free IV connectors include positive, negative, and neutral. Needle-free IV connectors are segmented by dwell time as seven-day dwell time and other than seven-day.

Key features of the study:

This report provides in-depth analysis of needle-free IV connectors and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global Needle-Free IV Connectors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans

Key companies covered as a part of this study include Baxter International, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA

According to the World Health Organization (WHO), annually around 1 million deaths are associated with the improper use of syringes and needles, which can be prevented by using needle-free IV connectors. Harmful diseases namely hepatitis and HIV can spread through improper and reuse of needles and syringes. Unsafe use of injections accounts for 5% of HIV, 40% of Hepatitis C and 32% of Hepatitis B virus infections globally. Although needle stick injuries are uncommon they are a potential problem, which can prove to be serious and are also responsible for causing above mentioned diseases. According to the Centers for Disease Control and Prevention (CDC), needle stick injuries account for around 385,000 among healthcare workers in the U.S annually. The most important goal while employing IV administration sets and needle-free connectors is to reduce the manipulation factor as much as possible. Some of the U.S. Food & Drug Administration (FDA) approved needle-free IV connectors include One-Link, CARESITE, MaxPlus, and Kendall.

“The global needle-free IV connectors market was valued at US$ 621.1 million in 2016 and is expected to reach a robust CAGR of 10.3% over the forecast period (2017-2025).”

Click To Reading More On Needle-free IV Connectors Market

About Coherent Market Insights:

#Needle-free IV Connectors Market #needle-free iv connectors #Needle-free IV Connectors Market Share #Needle-free IV Connectors Market Outlook #Needle-free IV Connectors Market Analysis

0 notes

healthcare00897 · 6 years ago

Text

U.S. Central Venous Catheter Market Business Segmentation by Revenue, Market Landscape, Present Scenario and Growth Prospects 2026

Central venous catheters consist of a long, thin tube that is inserted into a large vein to deliver medication, nutrition, intravenous fluids, and cancer medications. Different types of central venous catheters can be utilized by patients according to the duration of the treatment. These include, tunneled central venous catheters (CVC) and implanted ports for long term use, peripherally inserted central catheter (PICC) for intermediate term, and non-tunneled CVC for short term use. Central venous catheterization is used for chemotherapy administration, total parenteral nutrition, administration of intravenous fluids and blood, platelet transfusions, and other applications.

Market Dynamics

Increasing prevalence of renal diseases is a major factor driving the central venous catheter market growth. According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

Moreover, introduction of innovative products and increasing requirement of long-duration IV therapies such as chemotherapy is expected to boost the market growth. For instance, in May, 2018, Pursuit Vascular, Inc., received the U.S. Food and Drug Administration (FDA) clearance for a broader indication of its ClearGuard HD caps to include reduction in the incidence of central-line associated bloodstream infection (CLABSI) in hemodialysis patients with central venous catheters (CVCs).

Increasing prevalence of cancer is expected to propel growth of the central venous catheter market

Cancer is a class of chronic disease that is characterized by out-of-controlled growth of cells. According to The National Cancer Institute, 2013, there are over 100 different types of cancer that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/2610

According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

According to the World Health Organization (WHO), 2012, cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012. Furthermore, WHO stated that the number of new cases is expected to increase by around 70% by 2030. In 2015, cancer was responsible for 8.8 million deaths worldwide.

Increasing collaboration strategies adopted by market players is expected to bolster growth of the U.S. central venous catheter market

The U.S. central venous catheter market is expected to witness significant growth due to increasing adoption of collaboration strategies by market players. For instance, in 2017, Becton, Dickinson, and Company acquired C.R. Bard, Inc. which created a new health care industry leader with approximately US$ 16 billion in annualized revenue. Similarly, in July 2018, B.Braun Melsungen AG acquired the bloodlines business of NxStage Medical, Inc. This acquisition helped dialysis business of B. Braun Melsungen AG.

Key Players

Major players operating in the U.S. central venous catheter market include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation.

About Coherent Market Insights

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: [email protected]

#U.S. Central Venous Catheter MarketU.S. Central Venous Catheter trendsU.S. Central Venous Catheter growthU.S. Central Venous Catheter insigh

0 notes